Cimerli (Intraocular)

From 868.75$

Active Ingredients

ranibizumab

Drug Classes

Anti-angiogenic ophthalmic agents

Scoring is done by our AI based assistant on the data from the FDA and other sources

7.8

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

Cimerli (Intraocular): Alternative Drugs By Action

8.5

Brolucizumab ophthalmic

8.1

Beovu

7.8

Aflibercept

7.8

Cimerli (ophthalmic)

7.8

Cimerli (Intraocular)

7.8

Eylea Pre-filled Syringe

7.5

Susvimo Implant Kit (ophthalmic)

7.5

Macugen

7.4

Cimerli (Intraocular)

7.4

Byooviz (ophthalmic)

7.4

Eylea and Eylea HD

7.4

Eylea HD

7.4

Brolucizumab-dbll (Intraocular)

7.4

Ranibizumab (ophthalmic)

7.4

Avacincaptad pegol ophthalmic

7.4

Faricimab ophthalmic

6.9

Cimerli

6.7

Byooviz

6.7

Susvimo (ophthalmic)

6.7

Vabysmo